Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Engineering | 5 | 2020 | 85 | 1.460 |
Why?
|
| Hydrogels | 6 | 2026 | 126 | 1.400 |
Why?
|
| Biocompatible Materials | 4 | 2022 | 153 | 1.030 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2022 | 34 | 0.700 |
Why?
|
| Cartilage Oligomeric Matrix Protein | 2 | 2018 | 3 | 0.690 |
Why?
|
| Cartilage, Articular | 1 | 2022 | 79 | 0.670 |
Why?
|
| Chemical Warfare Agents | 1 | 2020 | 4 | 0.660 |
Why?
|
| Enzymes, Immobilized | 1 | 2020 | 17 | 0.650 |
Why?
|
| Organophosphorus Compounds | 1 | 2020 | 33 | 0.640 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2020 | 45 | 0.640 |
Why?
|
| Proteins | 3 | 2020 | 764 | 0.630 |
Why?
|
| Osteoarthritis | 1 | 2022 | 146 | 0.620 |
Why?
|
| Pesticides | 1 | 2020 | 58 | 0.610 |
Why?
|
| Protein Domains | 3 | 2019 | 153 | 0.580 |
Why?
|
| Nanocomposites | 1 | 2018 | 28 | 0.530 |
Why?
|
| Cellulase | 1 | 2017 | 5 | 0.510 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2017 | 11 | 0.510 |
Why?
|
| Nanoconjugates | 1 | 2017 | 5 | 0.510 |
Why?
|
| Peptides | 1 | 2020 | 587 | 0.480 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 2 | 2026 | 36 | 0.470 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 500 | 0.450 |
Why?
|
| Exosomes | 2 | 2026 | 53 | 0.440 |
Why?
|
| Wound Healing | 2 | 2026 | 193 | 0.430 |
Why?
|
| Tertiary Lymphoid Structures | 2 | 2025 | 5 | 0.420 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2013 | 9 | 0.410 |
Why?
|
| Integrin beta3 | 1 | 2013 | 8 | 0.410 |
Why?
|
| src Homology Domains | 1 | 2013 | 21 | 0.410 |
Why?
|
| Monascus | 2 | 2022 | 2 | 0.360 |
Why?
|
| Melanoma | 2 | 2023 | 332 | 0.300 |
Why?
|
| Models, Molecular | 3 | 2020 | 1160 | 0.300 |
Why?
|
| Doxorubicin | 2 | 2019 | 98 | 0.270 |
Why?
|
| Polymers | 2 | 2022 | 332 | 0.260 |
Why?
|
| Drug Carriers | 2 | 2019 | 188 | 0.240 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2026 | 20 | 0.240 |
Why?
|
| Protein Conformation | 2 | 2020 | 790 | 0.240 |
Why?
|
| Amino Acid Sequence | 2 | 2020 | 1589 | 0.230 |
Why?
|
| Immunoglobulin A | 1 | 2026 | 102 | 0.230 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2025 | 233 | 0.220 |
Why?
|
| RNA, Small Interfering | 2 | 2024 | 980 | 0.210 |
Why?
|
| Histidine | 1 | 2024 | 36 | 0.210 |
Why?
|
| Liposomes | 1 | 2024 | 116 | 0.200 |
Why?
|
| Oligopeptides | 1 | 2024 | 134 | 0.200 |
Why?
|
| Cancer Vaccines | 1 | 2023 | 51 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 1 | 2026 | 875 | 0.170 |
Why?
|
| Gels | 1 | 2022 | 77 | 0.170 |
Why?
|
| Rabbits | 1 | 2022 | 338 | 0.170 |
Why?
|
| Hydrolysis | 1 | 2020 | 147 | 0.160 |
Why?
|
| Chemical Phenomena | 1 | 2020 | 96 | 0.160 |
Why?
|
| Catalysis | 1 | 2020 | 163 | 0.160 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 354 | 0.150 |
Why?
|
| Theranostic Nanomedicine | 1 | 2019 | 9 | 0.150 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 710 | 0.150 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2019 | 37 | 0.150 |
Why?
|
| Neoplasms | 2 | 2026 | 1363 | 0.140 |
Why?
|
| Elastin | 1 | 2018 | 11 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 673 | 0.140 |
Why?
|
| Elasticity | 1 | 2018 | 45 | 0.140 |
Why?
|
| Spectrum Analysis | 1 | 2018 | 50 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2022 | 165 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 240 | 0.130 |
Why?
|
| Humans | 14 | 2026 | 64870 | 0.130 |
Why?
|
| Enzyme Stability | 1 | 2017 | 47 | 0.130 |
Why?
|
| Protein Multimerization | 1 | 2018 | 181 | 0.130 |
Why?
|
| Nanofibers | 2 | 2026 | 20 | 0.120 |
Why?
|
| Animals | 6 | 2026 | 21278 | 0.120 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 172 | 0.110 |
Why?
|
| Gold | 1 | 2018 | 235 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 333 | 0.110 |
Why?
|
| Metal Nanoparticles | 1 | 2018 | 190 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2026 | 206 | 0.110 |
Why?
|
| Gene Expression | 1 | 2018 | 852 | 0.110 |
Why?
|
| Reishi | 1 | 2014 | 2 | 0.100 |
Why?
|
| Anti-Allergic Agents | 1 | 2014 | 4 | 0.100 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2014 | 12 | 0.100 |
Why?
|
| Circular Dichroism | 1 | 2013 | 108 | 0.100 |
Why?
|
| Tyrosine | 1 | 2013 | 93 | 0.100 |
Why?
|
| Hypersensitivity | 1 | 2014 | 73 | 0.100 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 84 | 0.100 |
Why?
|
| Protein Binding | 2 | 2018 | 1638 | 0.100 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 81 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2019 | 544 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 642 | 0.090 |
Why?
|
| Protein Structure, Secondary | 2 | 2024 | 260 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2017 | 713 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 676 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 239 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 739 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 960 | 0.080 |
Why?
|
| Micelles | 2 | 2019 | 84 | 0.070 |
Why?
|
| MCF-7 Cells | 2 | 2019 | 65 | 0.070 |
Why?
|
| Temperature | 2 | 2019 | 314 | 0.070 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 281 | 0.070 |
Why?
|
| Immunity, Mucosal | 1 | 2026 | 53 | 0.060 |
Why?
|
| Cross Reactions | 1 | 2026 | 139 | 0.060 |
Why?
|
| Mice | 3 | 2026 | 11082 | 0.060 |
Why?
|
| Macaca mulatta | 1 | 2026 | 260 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2026 | 449 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2023 | 39 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 27 | 0.050 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2023 | 104 | 0.050 |
Why?
|
| Transfection | 1 | 2024 | 701 | 0.050 |
Why?
|
| Pigments, Biological | 1 | 2021 | 6 | 0.040 |
Why?
|
| Pigmentation | 1 | 2021 | 25 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2023 | 235 | 0.040 |
Why?
|
| Fermentation | 1 | 2021 | 52 | 0.040 |
Why?
|
| Rheology | 1 | 2021 | 83 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2022 | 221 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2023 | 574 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2022 | 130 | 0.040 |
Why?
|
| Antioxidants | 1 | 2022 | 249 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2021 | 148 | 0.040 |
Why?
|
| Fluorine | 1 | 2019 | 9 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2019 | 120 | 0.040 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 55 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 57 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 287 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2023 | 1035 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 1004 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2018 | 114 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2018 | 156 | 0.030 |
Why?
|
| Biomarkers | 1 | 2023 | 1472 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 327 | 0.030 |
Why?
|
| Patents as Topic | 1 | 2014 | 6 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2026 | 6828 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2014 | 29 | 0.030 |
Why?
|
| Male | 2 | 2026 | 30911 | 0.020 |
Why?
|
| Female | 2 | 2026 | 33877 | 0.020 |
Why?
|
| Aged | 1 | 2026 | 14899 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2233 | 0.020 |
Why?
|
| Middle Aged | 1 | 2026 | 18179 | 0.020 |
Why?
|